PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
PBA is a neurologic condition that is estimated to impact over a million patients and their
 families in the United States. PBA occurs secondary to an otherwise unrelated neurologic
 disease or injury, and manifests as involuntary, frequent, and disruptive outbursts of crying
 and/or laughing. Progress has been made in better understanding this debilitating condition,
 but much more needs to be done. That's why a new PBA patient registry, PRISM (Pseudobulbar
 Affect RegIstry Series), has been initiated.

 The goal of PRISM is to establish the prevalence and quality of life (QOL) impact of PBA in
 patients with underlying neurologic conditions including

 -  Alzheimer's disease

 -  Amyotrophic lateral sclerosis

 -  Multiple sclerosis

 -  Parkinson's disease

 -  Stroke

 -  Traumatic brain injury

 Because this is an observational registry, it doesn't require you to intervene with any
 specific treatment or procedure. Your participation allows the PRISM registry to collect and
 analyze data from your site and also compare it to national numbers captured in the PRISM
 registry about PBA across all of the major at-risk neurologic populations.
Inclusion Criteria:

 -  All participants must have underlying neurologic conditions known to be risk factors
 of PBA: Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis,
 Parkinson's Disease, Stroke, and Traumatic Brain Injury.

 -  The population for this study will be 18 years and over